85-5935-52　［取扱停止］Upadacitinib 1mg　CAS No:1310726-60-3　468468

特徴

• Upadacitinib also known as ABT-494, is a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders, Janus kinase inhibitors for rheumatoid arthritis.
• Synonyms:(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide, ABT-494
• Molecular Formula:C₁₇H₁₉F₃N₆O
• Molecular Weight:380.37
• Purity(HPLC, TLC):≥98%
• Appearance:Crystalline solid
• Solubility:DMSO:PBS (pH 7.2) (1:1): (0.50mg/ml)
• Storage and Stability:Lyophilized and reconstituted products are stable for 6 months after receipt at -20°C. Reconstitute with sterile DMSO:PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：1mg
• Grade：Highly Purified
• Molecular Formula：C₁₇H₁₉F₃N₆O
• Molecular Weight Non Ab：380.37
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
• CAS No ：1310726-60-3

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]